There is, what looks like, an excellent meeting in London, full details are on the SMR website. I hope I feel better by then.
SMR Award Meeting: Recent Disclosures of Clinical Candidates
10th December 2009
National Heart & Lung Institute, Kensington, London
|09.30||Registration and coffee|
|10.00||SMR Award lecture: The Discovery and development of Januvia™, Dr. Ann Weber, Merck|
(Introduction by - Rob Williams, Cancer Research UK)
|Session 1 - Chair: Mark Searcy, University of East Anglia|
|11.00 ||Chris Murray, Astex|
From fragment to clinic - the discovery of the hsp90 inhibitor, AT13387.
|11.45||George Muller, Celgene|
The discovery of apremilast.
|12.30||Lunch (Including SMR AGM 13.10-13.30)|
Session 2 - Chair: Diane Coe, GSK
|13.30||David Fox, Pfizer|
The discovery of a second generation long-acting PDE5 inhibitor.
|14.15||Simon Hodgson, GSK|
The discovery of a dual H1/H3 antagonist for allergic rhinitis.
|Session 3 - Chair: David Fox, Pfizer|
Karl Gibson, Pfizer
The discovery of a progesterone receptor antagonist for endometriosis.
|16.15||Mairi Gibson, GSK|
Second generation EP1 antagonists for the treatment of pain.